Problems and Examples of Biomolecule Inhalation for Systemic Treatment

@inproceedings{Siekmeiera2010ProblemsAE,
  title={Problems and Examples of Biomolecule Inhalation for Systemic Treatment},
  author={R. Siekmeiera and G. Scheuchb},
  year={2010}
}
  • R. Siekmeiera, G. Scheuchb
  • Published 2010
In recent decades a number of biomolecules, mostly peptides and proteins, have come into the focus of interest for inhalant administration as an alternative of parenteral delivery. Novel inhalation devices and optimization of the breathing technique enabled researchers to develop methods for the non-invasive administration of these compounds, especially for treatment of chronic systemic disorders (e.g. diabetes mellitus, anticoagulation). However, beside aspects of aerosol delivery and… CONTINUE READING

Figures from this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 32 REFERENCES

Treatment of systemic diseases by inhalation of biomolecule aerosols.

  • Journal of physiology and pharmacology : an official journal of the Polish Physiological Society
  • 2009

Inhaled insulin--does it become reality?

  • Journal of physiology and pharmacology : an official journal of the Polish Physiological Society
  • 2008

Systemic treatment by inhalation of macromolecules--principles, problems, and examples.

  • Journal of physiology and pharmacology : an official journal of the Polish Physiological Society
  • 2008

Anticoagulative effects of the inhaled low molecular weight heparin certoparin in healthy subjects.

  • Journal of physiology and pharmacology : an official journal of the Polish Physiological Society
  • 2007

Novel approaches to enhance pulmonary delivery of proteins and peptides.

  • Journal of physiology and pharmacology : an official journal of the Polish Physiological Society
  • 2007

A randomized trial of inhaled cyclosporine in lungtransplant recipients

JG Youssef, TE Corcoran, +8 authors BP Griffith
  • N Engl J Med
  • 2006